News mentioning KEYTRUDA QLEX
44 stories
May 14, 26Rintatolimod Plus Pembrolizumab and Cisplatin Displays 50% ORR in Recurrent Ovarian Cancer
May 13, 26Biomarker-Driven Treatment Decisions and Managing Progression After Frontline Immunotherapy
May 12, 26Dr McCann on the FDA Approval of Vepdegestrant for ESR1-Mutated, ER+ Advanced Breast Cancer
May 12, 26Unmet Needs in Endometrial Cancer
May 12, 26Sequencing ADCs in Endometrial Cancer
May 11, 26INBRX-106 Plus Pembrolizumab Yields Efficacy Benefit vs Pembrolizumab Alone in First-Line HNSCC
May 11, 26ctDNA in Metastatic Urothelial Carcinoma